Beyond Air, Inc. (XAIR) Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors

Go back to Beyond Air, Inc. (XAIR) Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors
(NASDAQ: XAIR) Delayed: 3.53 --0 (-0%)
Previous Close $3.53    52 Week High
Open $3.53    52 Week Low
Day High $3.53    P/E N/A 
Day Low $3.53    EPS
Volume 8,585